Technology | August 30, 2010

Cardiac Mapping System Launched in Japan

August 30, 2010 - A system was released in Japan last week that helps guide treatment of cardiac arrhythmias by creating a 3-D cardiac map and model based on the information from electrophysiology (EP) catheters.

St. Jude Medical is launching its EnSite Velocity Cardiac Mapping System. Advancements in the technology of both the hardware and software for the EnSite Velocity System were designed to increase procedural Cardiac Mapping System Launched in Japan, increase efficiency and speed, and potentially improve ease of use from set-up and operation to clinical application.

The new system hardware requires less space, offers a simpler set-up, using color-coding for each connector, and has an increased number of input channels. The software offers a completely re-designed and user friendly user interface that has two highly differentiated new capabilities:

OneMap Tool

The new OneMap tool allows physicians to create a detailed cardiac model and electrical map together using information from multiple catheters and electrodes. This feature offers the potential to assist physicians in collecting and displaying a greater amount of information in a shorter amount of time.

RealReview Function

The new RealReview function provides real-time, side-by-side views of the live procedure and previously recorded portions of the procedure. This enables physicians to view a quick and easy comparison of events and results at different times throughout the procedure without losing the ability to visualize and navigate catheters in real-time.

Because of the real time ability to display catheter location, the system has the longstanding ability to reduce fluoroscopy exposure. It also supports both contact and non-contact mapping, giving the EnSite Velocity System the ability to map any arrhythmia. The system’s open platform, offers compatibility with essentially all diagnostic and ablation catheters, recording systems and radiofrequency generators used for cardiac ablation procedures.

For more information: www.sjm.com

Related Content

Trial Data Shows Positive Predictive Results for Boston Scientific HeartLogic Heart Failure Diagnostic
News | Heart Failure| October 20, 2017
October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart F
Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement| October 19, 2017
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professio
The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure| October 18, 2017
October 18, 2017 — The U.S.
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab| September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Overlay Init